Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (23)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodrigo, G. J.
Right arrow Articles by Rodrigo, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodrigo, G. J.
Right arrow Articles by Rodrigo, C.
(Chest. 2000;118:1547-1552.)
© 2000 American College of Chest Physicians

Rapid-Onset Asthma Attack*

A Prospective Cohort Study About Characteristics and Response to Emergency Department Treatment

Gustavo J. Rodrigo, MD and Carlos Rodrigo, MD

* From the Departamento de Emergencia (Dr. G. J. Rodrigo), Hospital Central de las FF.AA.; and Unidad de Cuidado Intensivo (Dr. C. Rodrigo), Asociación Española 1a de Socorros Mutuos, Montevideo, Uruguay.

Correspondence to: Gustavo J. Rodrigo, MD, Departamento de Emergencia, Hospital Central de las FF.AA., Av. 8 de Octubre 3020, Montevideo 11600, Uruguay; e-mail: gurodrig{at}adinet.com.uy

Study objectives: (1) To determine the frequency of rapid-onset asthma attacks (ROAAs) and slow-onset asthma attacks (SOAAs) in adult patients with acute, severe disease (18 to 50 years old), who presented to an emergency department (ED); and (2) to establish whether ROAA patients differ from SOAA patients in terms of clinical and spirometric characteristics; and (3) in terms of the response of treatment.

Subjects and methods: Four hundred three patients (with peak expiratory flow [PEF] or FEV1 of < 50% of predicted value) with acute exacerbations of asthma were enrolled in the trial using a prospective cohort study. Asthma attacks were classified as an ROAA (< 6 h of symptoms) or an SOAA (>= 6 h). All patients were treated with albuterol, four puffs at 10-min intervals (100 µg per actuation), delivered by metered-dose inhaler with a spacer device during 3 h.

Results: On the basis of previously determined criteria, 11.3% of patients were classified as having a ROAA. Male patients comprised 53.6% of the ROAA group (p = 0.03). In ROAA patients, the exacerbation was less likely to be attributed to respiratory tract infection (p = 0.001) and more likely to have no identifiable cause (p = 0.0001). Also, ROAA patients had lower pulmonary function (FEV1) at presentation (mean difference, - 0.13; 95% confidence interval [CI], - 0.22 to - 0.04 L; p = 0.04) than SOAA patients. At the end of treatment, ROAA patients had an overall 48.0 L/min (95% CI, 14.1 to 81.8 L/min) greater improvement in PEF and a 0.31 L (95% CI, 0.08 to 0.54 L) greater improvement in FEV1 than SOAA patients. Also, ROAA patients presented with less accessory muscle use (p < 0.05) and higher oxygen saturation (p = 0.005). Finally, SOAA patients showed an increased incidence of hospital admission (relative risk, 3.89; 95% CI, 1.01 to 15.0).

Conclusions: Data from this study support the notion that ROAAs constitute a distinct but uncommon acute asthma ED presentation, with a predominance of male patients. Upper respiratory tract infection was not believed to be a significant trigger factor in these patients, and ROAA patients had rapid deterioration of their conditions followed by a more rapid response to treatment and a lower hospital admission rate than SOAA patients. Thus, we have identified a subgroup of patients who appear to have common characteristics with patients with sudden-onset near-fatal/fatal asthma.

Key Words: acute severe asthma • near-fatal asthma • sudden-onset asthma




This article has been cited by other articles:


Home page
ThoraxHome page
J M FitzGerald and P G Gibson
Asthma exacerbations {middle dot} 4: Prevention.
Thorax, November 1, 2006; 61(11): 992 - 999.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. L. James, J. G. Elliot, M. J. Abramson, and E. H. Walters
Time to death, airway wall inflammation and remodelling in fatal asthma
Eur. Respir. J., September 1, 2005; 26(3): 429 - 434.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
G J Rodrigo and C Rodrigo
Elevated plasma lactate level associated with high dose inhaled albuterol therapy in acute severe asthma
Emerg. Med. J., June 1, 2005; 22(6): 404 - 408.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
F. A. Maffei, E. W. van der Jagt, K. S. Powers, S. W. Standage, H. V. Connolly, W. G. Harmon, J. S. Sullivan, and J. S. Rubenstein
Duration of Mechanical Ventilation in Life-Threatening Pediatric Asthma: Description of an Acute Asphyxial Subgroup
Pediatrics, September 1, 2004; 114(3): 762 - 767.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. J. Rodrigo and C. Rodrigo
Triple Inhaled Drug Protocol for the Treatment of Acute Severe Asthma
Chest, June 1, 2003; 123(6): 1908 - 1915.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
V. Plaza, J. Serrano, C. Picado, and J. Sanchis
Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma
Eur. Respir. J., May 1, 2002; 19(5): 846 - 852.
[Abstract] [Full Text] [PDF]


Home page
JWatch Emergency Med.Home page
Rapid-Onset Asthma Attacks Are Different
Journal Watch Emergency Medicine, February 28, 2001; 2001(228): 1 - 1.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.